SelectQuote (SLQT)
NYSE:SLQT
Want to see SLQT full AI Analyst Report?
SLQT Stock Chart & Stats
$0.78
$0.12(2.90%)
At close: 4:00 PM EST
$0.78
$0.12(2.90%)
Day’s Range― - ―
52-Week Range$0.56 - $2.77
Previous CloseN/A
Volume368.25K
Average Volume (3M)1.09M
Market Cap
$209.85M
Enterprise Value$565.42M
Total Cash (Recent Filing)$35.21M
Total Debt (Recent Filing)$403.13M
Price to Earnings (P/E)0.7
Beta1.53
Next Earnings
Sep 16, 2026EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding176,347,780
10 Day Avg. Volume850,257
30 Day Avg. Volume1,094,945
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.73
Price to Sales (P/S)0.27
P/FCF Ratio-30.25
Enterprise Value/Market Cap2.69
Enterprise Value/Revenue0.34
Enterprise Value/Gross Profit0.58
Enterprise Value/Ebitda3.92
Forecast
1Y Price Target
$4.00Price Target Upside412.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.05
Revenue Forecast (FY)$1.65B
Bulls Say, Bears Say
Bulls Say
Platform & DistributionSelectQuote's tech-enabled DTC plus licensed agent distribution and carrier partnerships create a durable, multi-channel sales engine. Diversified product mix (Medicare, life, auto/home) and established call-center operations support steady lead conversion, recurring commissions and scale benefits over time.
Revenue Recovery & ProfitabilityThe firm has moved from losses toward sustained profitability and revenue growth, reflecting operational fixes and improved scale. Improved agent productivity and marketing efficiency (revenue-to-CAC ~6.7x) point to structurally better margins and long-term earnings power if cash conversion stabilizes.
Backbook Cash VisibilityA nearly $1B commissions receivable balance provides a durable backbook of predictable future cash flows from renewals and recaptures. Management's recapture metrics and receivable growth support multi-year cash visibility, which underpins deleveraging and recurring revenue generation if persistency holds.
Bears Say
Weak Cash GenerationDespite positive reported earnings, recurring operating and free cash flow were negative most recently, signaling that earnings haven't consistently converted to cash. Persistent negative cash flow raises funding, execution and deleveraging risks and could force strategic tradeoffs if it continues.
Listing-Compliance OverhangA formal NYSE non-compliance notice creates a structural governance and market-access risk until cured. The six-month cure window and potential need for shareholder actions can constrain strategic options, deter counterparties, and impose persistent overhang that affects capital-raising and long-term flexibility.
Earnings Sensitivity To AdjustmentsQuarterly profitability was materially aided by a $14M favorable estimate change to commissions receivable, highlighting sensitivity to accounting timing and estimate revisions. Reliance on non-recurring adjustments clouds organic margin sustainability and the quality of reported cash generation.
SelectQuote News
SLQT FAQ
What was SelectQuote’s price range in the past 12 months?
SelectQuote lowest stock price was $0.56 and its highest was $2.77 in the past 12 months.
What is SelectQuote’s market cap?
SelectQuote’s market cap is $209.85M.
When is SelectQuote’s upcoming earnings report date?
SelectQuote’s upcoming earnings report date is Sep 16, 2026 which is in 124 days.
How were SelectQuote’s earnings last quarter?
SelectQuote released its earnings results on May 05, 2026. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of -$0.008 by $0.118.
Is SelectQuote overvalued?
According to Wall Street analysts SelectQuote’s price is currently Undervalued.
Does SelectQuote pay dividends?
SelectQuote does not currently pay dividends.
What is SelectQuote’s EPS estimate?
SelectQuote’s EPS estimate is -0.17.
How many shares outstanding does SelectQuote have?
SelectQuote has 176,347,780 shares outstanding.
What happened to SelectQuote’s price movement after its last earnings report?
SelectQuote reported an EPS of $0.11 in its last earnings report, beating expectations of -$0.008. Following the earnings report the stock price went up 52.522%.
Which hedge fund is a major shareholder of SelectQuote?
Currently, no hedge funds are holding shares in SLQT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SelectQuote Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (412.82% Upside)
$4.00 (412.82% Upside)
Blogger Sentiment
Bullish
SLQT Sentiment 66%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 63.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $104.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.4%
Last 30 Days ▲ 1.5%
Last 30 Days ▲ 1.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.01%
12-Months-Change
Fundamentals
Return on Equity
15.28%
Trailing 12-Months
Asset Growth
3.00%
Trailing 12-Months
Company Description
SelectQuote
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance policies to consumers from various insurance carriers in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related policies, including prescription drugs, dental, vision, and hearing plans; term life policies; and non-commercial auto and home property, and casualty policies. The company was incorporated in 1999 and is headquartered in Overland Park, Kansas.
SLQT Company Deck
SLQT Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid operational and financial progress: revenue grew 6% to $431M, adjusted EBITDA rose 18% to $45M, Senior and Healthcare Services showed tangible improvements, SelectRx demonstrated membership and efficiency momentum, and management reiterated guidance and a path to stronger cash flow in fiscal 2027. Offsetting items include IRA-driven top-line effects, earlier PBM reimbursement headwinds (now reportedly stabilized), reliance on a $14M favorable change in estimate that aided results, and potential timing-related volatility in MA approval rates that could affect Q4. Management emphasized backbook visibility (nearly $1B commissions receivable) and multiple strategic options to close the valuation gap. On balance, operational strengths and clear pathways to improved cash flow outweigh the near-term headwinds and accounting nuances.View all SLQT earnings summariesSLQT Stock 12 Month Forecast
Average Price Target
$4.00
▲(412.82% Upside)
Technical Analysis
Ownership Overview
29.70% Insiders
7.45% Mutual Funds
1.89% Other Institutional Investors
52.16% Public Companies and
Individual Investors